Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PBM Standards Allow Preparation Of Formulary Reviews For P&T Committee

Executive Summary

Pharmacy benefit management standards developed by the trade association PCMA allow PBMs to provide an initial formulary review to an independent pharmacy and therapeutics committee.

You may also be interested in...



Manufacturer Compliance Programs For Medicare Advocated By Prosecutor

The establishment of a Medicare prescription drug benefit should trigger the creation of Medicare compliance programs within pharmaceutical companies, Philadelphia Assistant U.S. Attorney James Sheehan said.

Manufacturer Compliance Programs For Medicare Advocated By Prosecutor

The establishment of a Medicare prescription drug benefit should trigger the creation of Medicare compliance programs within pharmaceutical companies, Philadelphia Assistant U.S. Attorney James Sheehan said.

Rx Cost Management Should Emphasize Generics Over Rebates - BC/BS Exec

The goal for pharmacy managers should be a decline in drug budgets over the next few years in light of patent expirations, Regence Blue Shield of Idaho Assistant VP-Pharmacy Services Terrance Killilea told the Pharmaceutical Benefit Management Institute April 28 in Scottsdale, Ariz.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS036214

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel